Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Gusstoon Jan 26, 2018 3:53pm

221 Views

Post# 27443869

Level 2 looking good going into the close.

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.24	1586500	15	$0.245	18000	1
$0.235	1323500	10	$0.25	669500	40
$0.23	494500	14	$0.255	300000	17
$0.225	269500	9	$0.26	342500	20
$0.22	156000	10	$0.265	110500	6
$0.215	128000	3	$0.27	96500	16
$0.21	691500	8	$0.275	30500	4
$0.205	135000	4	$0.28	470000	15
$0.20	379000	21	$0.285	168000	8
$0.195	680500	20	$0.29	293000	13